KATHRYN BACCI: Open Payments
NPI 1861075392 · OAKHURST, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 17 payments from 10 companies in 2025. Trend: 2023 $302 · 2024 $172 · 2025 $516
Food & beverage: $431Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $191 |
| Intera Oncology, Inc | 1 | $88 |
| Janssen Biotech, Inc. | 1 | $85 |
| Ethicon US, LLC | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Tempus AI, Inc | 1 | $22 |
| Solventum Corporation | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Integra LifeSciences Corporation | 1 | $18 |
| Madrigal Pharmaceuticals | 1 | $14 |
Products named: INTERA, TREMFYA, LINZESS, ENTYVIO, XT CDX, PREVENA, RINVOQ, DUPIXENT.
Industry payments across NJ — which companies pay providers there.
